What is the price target for AbbVie stock?

According to analysts' consensus price target of $158.78, AbbVie has a forecasted downside of 1.8% from its current price of $161.61. AbbVie has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

What is the earnings per share for AbbVie Inc?

AbbVie Inc. (NYSE:ABBV) issued its quarterly earnings results on Friday, October, 28th. The company reported $3.66 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.56 by $0.10.

What is the consensus estimate for AbbVie Inc?

The consensus earnings estimate of $13.88 for the current fiscal year indicates a year-over-year change of +9.3%. This estimate has changed -0.2% over the last 30 days. For the next fiscal year, the consensus earnings estimate of $11.51 indicates a change of -17% from what AbbVie is expected to report a year ago.

What is the stock symbol for AbbVie?

AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.